-
1
-
-
0027942607
-
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
-
Aiello L.P., Avery R.L., Arrigg P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331 (1994) 1480-1487
-
(1994)
N Engl J Med
, vol.331
, pp. 1480-1487
-
-
Aiello, L.P.1
Avery, R.L.2
Arrigg, P.G.3
-
2
-
-
33748982649
-
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
-
Avery R.L., Pearlman J., Pieramici D.J., et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113 (2006) 1695-1705
-
(2006)
Ophthalmology
, vol.113
, pp. 1695-1705
-
-
Avery, R.L.1
Pearlman, J.2
Pieramici, D.J.3
-
3
-
-
0033021175
-
Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability
-
Bauriedel G., Hutter R., Welsch U., et al. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res 41 (1999) 480-488
-
(1999)
Cardiovasc Res
, vol.41
, pp. 480-488
-
-
Bauriedel, G.1
Hutter, R.2
Welsch, U.3
-
4
-
-
0029805172
-
Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly
-
Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am J Physiol 271 (1996) C1424-C1437
-
(1996)
Am J Physiol
, vol.271
-
-
Beckman, J.S.1
Koppenol, W.H.2
-
6
-
-
0035051114
-
Treatment of ischemic wounds using cultured dermal fibroblasts transduced retrovirally with PDGF-B and VEGF121 genes
-
Breitbart A.S., Grande D.A., Laser J., et al. Treatment of ischemic wounds using cultured dermal fibroblasts transduced retrovirally with PDGF-B and VEGF121 genes. Ann Plast Surg 46 (2001) 555-561
-
(2001)
Ann Plast Surg
, vol.46
, pp. 555-561
-
-
Breitbart, A.S.1
Grande, D.A.2
Laser, J.3
-
7
-
-
0142089171
-
Prognostic value of myeloperoxidase in patients with chest pain
-
Brennan M.L., Penn M.S., Van Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
-
(2003)
N Engl J Med
, vol.349
, pp. 1595-1604
-
-
Brennan, M.L.1
Penn, M.S.2
Van Lente, F.3
-
8
-
-
1942542429
-
Age-related macular degeneration is the leading cause of blindness
-
Bressler N.M. Age-related macular degeneration is the leading cause of blindness. JAMA 291 (2004) 1900-1901
-
(2004)
JAMA
, vol.291
, pp. 1900-1901
-
-
Bressler, N.M.1
-
9
-
-
33749451356
-
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
-
Brown D.M., Kaiser P.K., Michels M., et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1432-1444
-
(2006)
N Engl J Med
, vol.355
, pp. 1432-1444
-
-
Brown, D.M.1
Kaiser, P.K.2
Michels, M.3
-
10
-
-
0032406276
-
HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
-
Bustos C., Hernández-Presa M.A., Ortego M., et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 32 (1998) 2057-2064
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 2057-2064
-
-
Bustos, C.1
Hernández-Presa, M.A.2
Ortego, M.3
-
11
-
-
0345167094
-
Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelization and reduce vascular inflammation after Intravascular radiation
-
Cho H.J., Kim H.S., Lee M.M., et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelization and reduce vascular inflammation after Intravascular radiation. Circulation 108 (2003) 2918-2925
-
(2003)
Circulation
, vol.108
, pp. 2918-2925
-
-
Cho, H.J.1
Kim, H.S.2
Lee, M.M.3
-
12
-
-
34147190880
-
FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer
-
Cohen M.H., Gootenberg J., Keegan P., and Pazdur R. FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer. Oncologist 12 (2007) 356-361
-
(2007)
Oncologist
, vol.12
, pp. 356-361
-
-
Cohen, M.H.1
Gootenberg, J.2
Keegan, P.3
Pazdur, R.4
-
15
-
-
0029800916
-
Stability and instability: two faces of coronary atherosclerosis
-
Davies M.J. Stability and instability: two faces of coronary atherosclerosis. Circulation 94 (1996) 2013-2020
-
(1996)
Circulation
, vol.94
, pp. 2013-2020
-
-
Davies, M.J.1
-
16
-
-
0037432168
-
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes
-
de Lemos J.A., Morrow D.A., Sabatine M.S., et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 107 (2003) 690-695
-
(2003)
Circulation
, vol.107
, pp. 690-695
-
-
de Lemos, J.A.1
Morrow, D.A.2
Sabatine, M.S.3
-
17
-
-
0034466813
-
Pharmacokinetics and safety of an antivascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys
-
Drolet D.W., Nelson J., Tucker C.E., et al. Pharmacokinetics and safety of an antivascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharm Res 17 (2000) 1503-1510
-
(2000)
Pharm Res
, vol.17
, pp. 1503-1510
-
-
Drolet, D.W.1
Nelson, J.2
Tucker, C.E.3
-
18
-
-
33947601440
-
Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans
-
Duan Y., Mo J., Klein R., et al. Age-related macular degeneration is associated with incident myocardial infarction among elderly Americans. Ophthalmology 114 (2007) 732-737
-
(2007)
Ophthalmology
, vol.114
, pp. 732-737
-
-
Duan, Y.1
Mo, J.2
Klein, R.3
-
19
-
-
0000324895
-
Pathogenesis of plaque disruption
-
Fuster V., Ross R., and Topol E.J. (Eds), Lippincott-Raven, Philadelphia
-
Falk E., Shah P.K., and Fuster V. Pathogenesis of plaque disruption,. In: Fuster V., Ross R., and Topol E.J. (Eds). Atherosclerosis and Coronary Artery Disease (1996), Lippincott-Raven, Philadelphia 491-507
-
(1996)
Atherosclerosis and Coronary Artery Disease
, pp. 491-507
-
-
Falk, E.1
Shah, P.K.2
Fuster, V.3
-
20
-
-
4143136640
-
Vascular endothelial growth factor: basic science and clinical progress
-
Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25 (2004) 581-611
-
(2004)
Endocr Rev
, vol.25
, pp. 581-611
-
-
Ferrara, N.1
-
21
-
-
0031039243
-
The biology of vascular endothelial growth factor
-
Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
-
(1997)
Endocr Rev
, vol.18
, pp. 4-25
-
-
Ferrara, N.1
Davis-Smyth, T.2
-
22
-
-
0037699954
-
The biology of VEGF and its receptors
-
Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
-
(2003)
Nat Med
, vol.9
, pp. 669-676
-
-
Ferrara, N.1
Gerber, H.P.2
LeCouter, J.3
-
23
-
-
0021752680
-
Age-related macular degeneration and blindness due to neovascular maculopathy
-
Ferris F.L., Fine S.L., and Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 102 (1984) 1640-1642
-
(1984)
Arch Ophthalmol
, vol.102
, pp. 1640-1642
-
-
Ferris, F.L.1
Fine, S.L.2
Hyman, L.3
-
24
-
-
4844231461
-
Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation
-
Fliser D., Buchholz K., Haller H., et al. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 110 (2004) 1103-1107
-
(2004)
Circulation
, vol.110
, pp. 1103-1107
-
-
Fliser, D.1
Buchholz, K.2
Haller, H.3
-
25
-
-
0035956947
-
Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability
-
Fukumara D., Gohongi T., Kadambi A., et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98 (2001) 2604-2609
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 2604-2609
-
-
Fukumara, D.1
Gohongi, T.2
Kadambi, A.3
-
26
-
-
0012746898
-
Coronary artery disease: a clinical-pathological correlation
-
Fuster V. (Ed), Futura Publishing, New York
-
Fuster V. Coronary artery disease: a clinical-pathological correlation,. In: Fuster V. (Ed). Syndromes of Atherosclerosis (1996), Futura Publishing, New York 1-15
-
(1996)
Syndromes of Atherosclerosis
, pp. 1-15
-
-
Fuster, V.1
-
27
-
-
0027125530
-
The pathogenesis of coronary artery disease and the acute coronary syndromes
-
310-8
-
Fuster V., Badimon L., Badimon J.J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326 (1992) 242-250 310-8
-
(1992)
N Engl J Med
, vol.326
, pp. 242-250
-
-
Fuster, V.1
Badimon, L.2
Badimon, J.J.3
Chesebro, J.H.4
-
28
-
-
13944266313
-
Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration
-
Gaudreault J., Fei D., Rusit J., et al. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci 46 (2005) 726-733
-
(2005)
Invest Ophthalmol Vis Sci
, vol.46
, pp. 726-733
-
-
Gaudreault, J.1
Fei, D.2
Rusit, J.3
-
29
-
-
0032557564
-
Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
-
Gerber H.P., Dixit V., Ferrara N., et al. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273 (1998) 13313-13316
-
(1998)
J Biol Chem
, vol.273
, pp. 13313-13316
-
-
Gerber, H.P.1
Dixit, V.2
Ferrara, N.3
-
30
-
-
0032931234
-
VEGF is required for growth and survival in neonatal mice
-
Gerber H.P., Hillan K.J., Ryan, et al. VEGF is required for growth and survival in neonatal mice. Development 126 (1999) 1149-1159
-
(1999)
Development
, vol.126
, pp. 1149-1159
-
-
Gerber, H.P.1
Hillan, K.J.2
Ryan3
-
31
-
-
0032515047
-
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
-
Gerber H.P., McMurtrey A., Kowalski J., et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273 (1998) 30336-30343
-
(1998)
J Biol Chem
, vol.273
, pp. 30336-30343
-
-
Gerber, H.P.1
McMurtrey, A.2
Kowalski, J.3
-
32
-
-
34248173883
-
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200
-
Giantonio B.J., Catalano P.J., Meropol M.J., et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25 (2007) 1539-1544
-
(2007)
J Clin Oncol
, vol.25
, pp. 1539-1544
-
-
Giantonio, B.J.1
Catalano, P.J.2
Meropol, M.J.3
-
33
-
-
33846973644
-
Ranibizumab for neovascular age-related macular degeneration
-
Gillies M.C., and Wong T.Y. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 356 (2007) 748-750
-
(2007)
N Engl J Med
, vol.356
, pp. 748-750
-
-
Gillies, M.C.1
Wong, T.Y.2
-
34
-
-
0034255465
-
Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia
-
Gowdak L.H., Poliakova L., Wang X., et al. Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia. Circulation 102 (2000) 565-571
-
(2000)
Circulation
, vol.102
, pp. 565-571
-
-
Gowdak, L.H.1
Poliakova, L.2
Wang, X.3
-
35
-
-
11144239923
-
Pegaptanib for neovascular age-related macular degeneration
-
Gragoudas E.S., Adamis A., Cunningham E.T., et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
-
(2004)
N Engl J Med
, vol.351
, pp. 2805-2816
-
-
Gragoudas, E.S.1
Adamis, A.2
Cunningham, E.T.3
-
36
-
-
0027452475
-
Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture
-
Green W.R., and Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 100 (1993) 1519-1535
-
(1993)
Ophthalmology
, vol.100
, pp. 1519-1535
-
-
Green, W.R.1
Enger, C.2
-
37
-
-
0028365310
-
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
-
Griendling K.H., Mineri C.A., Ollerenshaw J.D., and Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74 (1994) 1141-1148
-
(1994)
Circ Res
, vol.74
, pp. 1141-1148
-
-
Griendling, K.H.1
Mineri, C.A.2
Ollerenshaw, J.D.3
Alexander, R.W.4
-
38
-
-
21144443076
-
Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF
-
Guba M., Yezhelyev M., Eichhorn M.E., et al. Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF. Blood 105 (2005) 4463-4469
-
(2005)
Blood
, vol.105
, pp. 4463-4469
-
-
Guba, M.1
Yezhelyev, M.2
Eichhorn, M.E.3
-
39
-
-
0037453099
-
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis
-
Henry T.D., Annex B.H., McKendall G.R., et al. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation 107 (2003) 1359-1365
-
(2003)
Circulation
, vol.107
, pp. 1359-1365
-
-
Henry, T.D.1
Annex, B.H.2
McKendall, G.R.3
-
40
-
-
0030950540
-
Angiotensin Converting enzyme inhibition prevents arterial NF-kB activation, MCP-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis
-
Hernández-Presa M., Bustos C., Ortego M., et al. Angiotensin Converting enzyme inhibition prevents arterial NF-kB activation, MCP-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95 (1997) 1532-1541
-
(1997)
Circulation
, vol.95
, pp. 1532-1541
-
-
Hernández-Presa, M.1
Bustos, C.2
Ortego, M.3
-
41
-
-
0036147982
-
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells
-
Hernández-Presa M.A., Martín-Ventura J.L., Ortego M., et al. Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. Atherosclerosis 160 (2002) 49-58
-
(2002)
Atherosclerosis
, vol.160
, pp. 49-58
-
-
Hernández-Presa, M.A.1
Martín-Ventura, J.L.2
Ortego, M.3
-
42
-
-
0026395163
-
The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA
-
Houck K.A., Ferrara N., Winer J., et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5 (1991) 1806-1814
-
(1991)
Mol Endocrinol
, vol.5
, pp. 1806-1814
-
-
Houck, K.A.1
Ferrara, N.2
Winer, J.3
-
43
-
-
0027064888
-
Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
-
Houck K.A., Leung D.W., Rowland A.M., et al. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267 (1992) 26031-26037
-
(1992)
J Biol Chem
, vol.267
, pp. 26031-26037
-
-
Houck, K.A.1
Leung, D.W.2
Rowland, A.M.3
-
44
-
-
6444220780
-
Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury
-
Huttler R., Carrick F.E., Valdiviezo C., et al. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation 110 (2004) 2430-2435
-
(2004)
Circulation
, vol.110
, pp. 2430-2435
-
-
Huttler, R.1
Carrick, F.E.2
Valdiviezo, C.3
-
45
-
-
0033594888
-
Novel mechanism for endothelial dysfunction. Dysregulation of dimethylarginine dimethylaminohydrolase
-
I to A., Tsao P.S., Adimoolam S., et al. Novel mechanism for endothelial dysfunction. Dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99 (1999) 3092-3095
-
(1999)
Circulation
, vol.99
, pp. 3092-3095
-
-
I to, A.1
Tsao, P.S.2
Adimoolam, S.3
-
46
-
-
0026534274
-
Platelet-derived growth factor promotes smooth-muscle migration and intimal thickening in a rat model of balloon angioplasty
-
Jawien A., Bowen-Pope D.F., Lindner V., et al. Platelet-derived growth factor promotes smooth-muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89 (1992) 507-511
-
(1992)
J Clin Invest
, vol.89
, pp. 507-511
-
-
Jawien, A.1
Bowen-Pope, D.F.2
Lindner, V.3
-
48
-
-
0037208589
-
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
-
Kabbinavar F., Hurwitz H.I., Fehrenbacher L., et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 21 (2003) 60-65
-
(2003)
J Clin Oncol
, vol.21
, pp. 60-65
-
-
Kabbinavar, F.1
Hurwitz, H.I.2
Fehrenbacher, L.3
-
49
-
-
34248639027
-
Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?
-
Kolodgie F.D., Narula J., Yuan C., et al. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?. J Am Coll Cardiol 49 (2007) 2093-2101
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 2093-2101
-
-
Kolodgie, F.D.1
Narula, J.2
Yuan, C.3
-
50
-
-
34249695008
-
Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neaovascularization due to age-related macular degeneration
-
Lazic R., and Gabric N. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neaovascularization due to age-related macular degeneration. Ophthalmology 114 (2007) 1179-1185
-
(2007)
Ophthalmology
, vol.114
, pp. 1179-1185
-
-
Lazic, R.1
Gabric, N.2
-
51
-
-
0024818355
-
Vascular endothelial growth factor is a secreted angiogenic mitogen
-
Leung D.W., Cachianes G., Kuang W.J., et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
-
(1989)
Science
, vol.246
, pp. 1306-1309
-
-
Leung, D.W.1
Cachianes, G.2
Kuang, W.J.3
-
52
-
-
34548262708
-
Pegaptanib 1-year systemic safety results from a safety pharmacokinetic trial in patients with neovascular age-related macular degeneration
-
. Macugen AMD Study Group
-
Apte R.S., Modi M., et al., . Macugen AMD Study Group. Pegaptanib 1-year systemic safety results from a safety pharmacokinetic trial in patients with neovascular age-related macular degeneration. Ophthalmology 114 (2007) 1702-1712
-
(2007)
Ophthalmology
, vol.114
, pp. 1702-1712
-
-
Apte, R.S.1
Modi, M.2
-
53
-
-
0032891440
-
Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques. A role for apoptosis in plaque thrombogenicity
-
Mallat Z., Bénédicte H., Ohan J., et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques. A role for apoptosis in plaque thrombogenicity. Circulation 99 (1999) 348-353
-
(1999)
Circulation
, vol.99
, pp. 348-353
-
-
Mallat, Z.1
Bénédicte, H.2
Ohan, J.3
-
54
-
-
23244447710
-
Intensive treatment with atorvastatin reduces blood and plaque inflammation in patients with atherosclerotic lesions in one month
-
Martín-Ventura J.L., Blanco-Colio L.M., Gómez-Hernández A., et al. Intensive treatment with atorvastatin reduces blood and plaque inflammation in patients with atherosclerotic lesions in one month. Stroke 36 (2005) 1796-1800
-
(2005)
Stroke
, vol.36
, pp. 1796-1800
-
-
Martín-Ventura, J.L.1
Blanco-Colio, L.M.2
Gómez-Hernández, A.3
-
55
-
-
20844438189
-
Circulating heat shock protein-27 is decreased in patients with carotid stenosis. A potential novel marker of atherosclerosis
-
Martin-Ventura J.L., Duran M.C., Blanco-Colio L.M., et al. Circulating heat shock protein-27 is decreased in patients with carotid stenosis. A potential novel marker of atherosclerosis. Circulation 110 (2004) 2216-2219
-
(2004)
Circulation
, vol.110
, pp. 2216-2219
-
-
Martin-Ventura, J.L.1
Duran, M.C.2
Blanco-Colio, L.M.3
-
56
-
-
0025883342
-
Nitric oxide: physiology, pathophysiology, and pharmacology
-
Moncada S., Palmer R.M.J., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 93 (1991) 109-142
-
(1991)
Pharmacol Rev
, vol.93
, pp. 109-142
-
-
Moncada, S.1
Palmer, R.M.J.2
Higgs, E.A.3
-
57
-
-
0028139239
-
Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro
-
Nicosia R., Nicosia S.V., and Smith M. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145 (1994) 1023-1029
-
(1994)
Am J Pathol
, vol.145
, pp. 1023-1029
-
-
Nicosia, R.1
Nicosia, S.V.2
Smith, M.3
-
58
-
-
0032580971
-
Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis
-
Oemar B.S., Tschudi M.R., Godoy N., et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97 (1998) 2494-2498
-
(1998)
Circulation
, vol.97
, pp. 2494-2498
-
-
Oemar, B.S.1
Tschudi, M.R.2
Godoy, N.3
-
59
-
-
0029838582
-
Reversing endothelial dysfunction with ACE inhibitors. A new trend?
-
Rajagopalan S., and Harrison D.G. Reversing endothelial dysfunction with ACE inhibitors. A new trend?. Circulation 94 (1996) 240-243
-
(1996)
Circulation
, vol.94
, pp. 240-243
-
-
Rajagopalan, S.1
Harrison, D.G.2
-
60
-
-
0017662752
-
Multiple pathways of capillary permeability
-
Renkin E.M. Multiple pathways of capillary permeability. Circ Res 41 (1977) 735-743
-
(1977)
Circ Res
, vol.41
, pp. 735-743
-
-
Renkin, E.M.1
-
61
-
-
0034704893
-
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
-
Ridker P.M., Hennekens C.H., Buring J.E., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
-
(2000)
N Engl J Med
, vol.342
, pp. 836-843
-
-
Ridker, P.M.1
Hennekens, C.H.2
Buring, J.E.3
-
62
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
Rosenfeld P.J., Brown D.M., Heier J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
-
(2006)
N Engl J Med
, vol.355
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
-
63
-
-
0033520056
-
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
-
Rosengart T.K., Lee L.Y., Patel S.R., et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100 (1999) 468-474
-
(1999)
Circulation
, vol.100
, pp. 468-474
-
-
Rosengart, T.K.1
Lee, L.Y.2
Patel, S.R.3
-
64
-
-
0033552883
-
Atherosclerosis: an inflammatory disease
-
Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340 (1999) 115-126
-
(1999)
N Engl J Med
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
65
-
-
0342424181
-
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary artery disease
-
Schächinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary artery disease. Circulation 101 (2000) 1899-1906
-
(2000)
Circulation
, vol.101
, pp. 1899-1906
-
-
Schächinger, V.1
Britten, M.B.2
Zeiher, A.M.3
-
66
-
-
0343797053
-
Coronary atherosclerotic disease: pathological background
-
Fuster V. (Ed), Futura Publishing, New York
-
Schwartz C.J., and Chandler A.B. Coronary atherosclerotic disease: pathological background,. In: Fuster V. (Ed). Syndromes of Atherosclerosis (1996), Futura Publishing, New York 17-32
-
(1996)
Syndromes of Atherosclerosis
, pp. 17-32
-
-
Schwartz, C.J.1
Chandler, A.B.2
-
67
-
-
0035106148
-
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium
-
Schwesinger C., Yee C., and Rohan R.M. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 158 (2001) 1161-1172
-
(2001)
Am J Pathol
, vol.158
, pp. 1161-1172
-
-
Schwesinger, C.1
Yee, C.2
Rohan, R.M.3
-
68
-
-
0027298232
-
The endothelium as a regulator of vascular smooth muscle proliferation
-
Scott-Burden T., and Vanhoutte P.M. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation 87 Suppl V (1993) V51-V55
-
(1993)
Circulation
, vol.87
, Issue.SUPPL. V
-
-
Scott-Burden, T.1
Vanhoutte, P.M.2
-
69
-
-
0021111648
-
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
-
Senger D.R., Galli S.J., Dvorak A.M., et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219 (1983) 983-985
-
(1983)
Science
, vol.219
, pp. 983-985
-
-
Senger, D.R.1
Galli, S.J.2
Dvorak, A.M.3
-
70
-
-
0034948743
-
Host bone-marrow cells are a source of donor intimal smooth muscle-like cells In murine aortic transplant arteriopathy
-
Shimizu K., Sugiyama S., Aikawa M., et al. Host bone-marrow cells are a source of donor intimal smooth muscle-like cells In murine aortic transplant arteriopathy. Nat Med 7 (2001) 738-741
-
(2001)
Nat Med
, vol.7
, pp. 738-741
-
-
Shimizu, K.1
Sugiyama, S.2
Aikawa, M.3
-
71
-
-
6444228734
-
The role of vascular endothelial growth factor in restenosis: the controversy continues
-
Shiojima I., and Walsh K. The role of vascular endothelial growth factor in restenosis: the controversy continues. Circulation 110 (2004) 2283-2286
-
(2004)
Circulation
, vol.110
, pp. 2283-2286
-
-
Shiojima, I.1
Walsh, K.2
-
72
-
-
16344389190
-
Angiogenesis: Where do we stand now?
-
Simons M. Angiogenesis: Where do we stand now?. Circulation 111 (2005) 1556-1566
-
(2005)
Circulation
, vol.111
, pp. 1556-1566
-
-
Simons, M.1
-
73
-
-
33745091547
-
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
-
Spaide R.F., Laud K., Fine H.F., et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26 (2006) 383-390
-
(2006)
Retina
, vol.26
, pp. 383-390
-
-
Spaide, R.F.1
Laud, K.2
Fine, H.F.3
-
74
-
-
0010596633
-
Interaction between serum lipoproteins and cellular components of the arterial wall
-
Stein Y., and Stein O. Interaction between serum lipoproteins and cellular components of the arterial wall. Biochem 7 (1977) 313-344
-
(1977)
Biochem
, vol.7
, pp. 313-344
-
-
Stein, Y.1
Stein, O.2
-
75
-
-
0034791188
-
Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy
-
Suga S., Kim Y.G., Joly A., et al. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Kidney Int 60 (2001) 1297-1308
-
(2001)
Kidney Int
, vol.60
, pp. 1297-1308
-
-
Suga, S.1
Kim, Y.G.2
Joly, A.3
-
76
-
-
0001654669
-
Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
-
Suwaidi J.A., Hamasaki S., Higano S.T., et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000) 948-954
-
(2000)
Circulation
, vol.101
, pp. 948-954
-
-
Suwaidi, J.A.1
Hamasaki, S.2
Higano, S.T.3
-
77
-
-
0025999033
-
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
-
Tischer E., Mitchell R., Hartman T., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266 (1995) 11947-11954
-
(1995)
J Biol Chem
, vol.266
, pp. 11947-11954
-
-
Tischer, E.1
Mitchell, R.2
Hartman, T.3
-
78
-
-
0029739620
-
Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate
-
Tolentino M.J., Miller J.W., Gragoudas E.S., et al. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol 114 (1996) 964-970
-
(1996)
Arch Ophthalmol
, vol.114
, pp. 964-970
-
-
Tolentino, M.J.1
Miller, J.W.2
Gragoudas, E.S.3
-
79
-
-
16944365813
-
Tissue factor modulates the thrombogenicity of human atherosclerotic plaques
-
Toschi V., Gallo R., Lettino M., et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 95 (1997) 594-599
-
(1997)
Circulation
, vol.95
, pp. 594-599
-
-
Toschi, V.1
Gallo, R.2
Lettino, M.3
-
80
-
-
34248646760
-
Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?
-
Tziakas D.N., Kaski J.C., Chalikias G.K., et al. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?. J Am Coll Cardiol 49 (2007) 2081-2089
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 2081-2089
-
-
Tziakas, D.N.1
Kaski, J.C.2
Chalikias, G.K.3
-
81
-
-
0023678963
-
The endothelium: modulator of vascular smooth-muscle tone
-
Vanhoutte P.M. The endothelium: modulator of vascular smooth-muscle tone. N Engl J Med 319 (1988) 512-513
-
(1988)
N Engl J Med
, vol.319
, pp. 512-513
-
-
Vanhoutte, P.M.1
-
82
-
-
33646948521
-
Pegaptanib sodium for neovascular age-related macular degeneration. Two-year safety results of the two prospective, multicenter, controlled clinical trials
-
VEGF inhibition study in ocular neovascularisation (VISION) clinical trial group
-
VEGF inhibition study in ocular neovascularisation (VISION) clinical trial group. Pegaptanib sodium for neovascular age-related macular degeneration. Two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113 (1996) 992-1001
-
(1996)
Ophthalmology
, vol.113
, pp. 992-1001
-
-
-
83
-
-
0033506713
-
Cellular mechanisms of blood-retinal barrier dysfunction in macular edema
-
Vinores S.A., Derevkanik N.L., Ozaki H., et al. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol 97 (1999) 217-228
-
(1999)
Doc Ophthalmol
, vol.97
, pp. 217-228
-
-
Vinores, S.A.1
Derevkanik, N.L.2
Ozaki, H.3
-
84
-
-
0033000420
-
Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo
-
Weltermann A., Wolzt M., Petersmann K., et al. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo. Arterioscler Thromb Vasc Biol 19 (1999) 1757-1760
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 1757-1760
-
-
Weltermann, A.1
Wolzt, M.2
Petersmann, K.3
-
85
-
-
0033514984
-
Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages
-
Xu X.P., Meisel S.R., Ong J.M., et al. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99 (1999) 993-998
-
(1999)
Circulation
, vol.99
, pp. 993-998
-
-
Xu, X.P.1
Meisel, S.R.2
Ong, J.M.3
-
86
-
-
0042343801
-
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
-
Yang J.C., Haworth L., Sherry R.M., et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N Engl J Med 349 (2003) 427-434
-
(2003)
N Engl J Med
, vol.349
, pp. 427-434
-
-
Yang, J.C.1
Haworth, L.2
Sherry, R.M.3
-
87
-
-
0030022917
-
Effects of vascular endothelial growth factor on hemodynamics and cardiac performance
-
Yang R., Thomas G.R., Bunting S., et al. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol 27 (1996) 838-844
-
(1996)
J Cardiovasc Pharmacol
, vol.27
, pp. 838-844
-
-
Yang, R.1
Thomas, G.R.2
Bunting, S.3
|